Showing results (21-30 of 920) with videos related to
Sort By:
Pageof 92
Metabolism: Clinical and Experimental|May 5, 2023
Loss of metabolic adaptation in lean MAFLD is driven by endotoxemia leading to epigenetic reprogrammingJawaher Alharthi, Ziyan Pan, Brian S Gloss, et al.Journal of Medical Internet Research|November 12, 2024
Telehealth Use and Legal Considerations in Drug Health Services During Pandemics: Systematic Scoping ReviewMeryem Jefferies, Robert Graham, Marguerite Tracy, et al.Hepatology International|September 7, 2022
MAFLD, patient-centred care, and APASLShiv K Sarin, Mohammed Eslam, Jian-Gao Fan, et al.Cytokine|August 25, 2018
The role of IFN in the development of NAFLD and NASHMichelle Møhlenberg, Ewa Terczynska-Dyla, Karen Louise Thomsen, et al.Nature Reviews. Gastroenterology & Hepatology|June 17, 2022
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weightMohammed Eslam, Hashem B El-Serag, Sven Francque, et al.Nature Reviews. Gastroenterology & Hepatology|September 21, 2017
Global burden of NAFLD and NASH: trends, predictions, risk factors and preventionZobair Younossi, Quentin M Anstee, Milena Marietti, et al.DNA and Cell Biology|May 31, 2024
MERTK and Fibrosis: A New Target for TherapyZiyan Pan, Mohammed EslamJournal of Clinical and Translational Hepatology|March 2, 2022
Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An UpdateJawaher Alharthi, Mohammed EslamLiver International : Official Journal of the International Association for the Study of the Liver|August 25, 2025
Metabolic Divergence Between MASLD and Metabolic Syndrome: Distinct Clinical Phenotypes and Risk Stratification ImplicationsMariana M Ramírez-Mejía, Sandra M Barbalho, Guadalupe Ponciano-Rodríguez, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 30, 2020
MAFLD identifies patients with significant hepatic fibrosis better than NAFLDSakura Yamamura, Mohammed Eslam, Takumi Kawaguchi, et al.Pageof 92